Garaci et al., 1992, 1997
Common Protocol: Tesamorelin: 1 mg daily, subcutaneous BPC-157: 250500 mcg daily TB500: 25 mg per week Cycle: 812 weeks, often used post-injury or during high-recovery phases Key Notes: Peptides can be cycled to avoid desensitization and maintain effectiveness
By working with your bodys natural processes, these medications: Slow stomach emptying, helping you feel full longer and reducing unnecessary snacking
Its important to work with Dr Sende Wellness when making dietary changes
Critical Considerations and Potential Downsides It would be irresponsible to discuss the potential synergies without an unflinching look at the complexities and risks involved in such research
The reality is that there are currently no standardized clinical studies showing predictable weight-loss outcomes from BPC-157 use